Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
H.B. Fuller CoFRA:HB1 +1.87%81 EV-to-EBIT is 13.90 as of Aug. 19, 2026, which is 18% below its 10-year median of 17.05. GuruFocus rates FRA:HB1 with a GF Score™ of 81/100 and a GF Value™ of €61.38. The stock has 5 warning signs investors should review. Among 1,258 Chemicals companies, H.B. Fuller Co ranks better than 60.1% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
H.B. Fuller Co's Enterprise Value for the quarter that ended in May. 2026 was €4,581 Mil.
H.B. Fuller Co's EBIT for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €322 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
H.B. Fuller Co EV-to-EBIT Related Terms
H.B. Fuller Co EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for H.B. Fuller Co's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, H.B. Fuller Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
H.B. Fuller Co EV-to-EBIT vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, H.B. Fuller Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where H.B. Fuller Co's EV-to-EBIT falls into.
H.B. Fuller Co's current Enterprise Value is €4,472 Mil.
H.B. Fuller Co's EBIT for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €322 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
H.B. Fuller Co (FRA:HB1) has a EV-to-EBIT of 13.90 as of Aug. 19, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on H.B. Fuller Co and its competitors. This is 18% below median its historical median of 17.05. Over the past decade, H.B. Fuller Co's EV-to-EBIT has ranged from 11.93 to 48.97. According to the industry distribution chart, H.B. Fuller Co ranks #502 out of 1258 companies in the Chemicals industry, placing it in the top 39.9%.
Is H.B. Fuller Co's EV-to-EBIT too high?
H.B. Fuller Co's current EV-to-EBIT of 13.90 is 18% below median its 10-year median of 17.05. Over the past 10 years, this metric has ranged from a low of 11.93 to a high of 48.97. The Chemicals industry median EV-to-EBIT is 17.47. H.B. Fuller Co's value of 13.90 is 20.4% below this industry median. Based on the distribution chart, H.B. Fuller Co ranks #502 out of 1258 companies in the Chemicals industry, which is above the industry midpoint. Overall, H.B. Fuller Co has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does H.B. Fuller Co's EV-to-EBIT compare to ASH and HWKN?
According to the Chemicals industry distribution chart, H.B. Fuller Co ranks #502 out of 1258 companies for EV-to-EBIT. This puts H.B. Fuller Co in the upper half of its industry. The industry median EV-to-EBIT is 17.47. H.B. Fuller Co's value of 13.90 is 20.4% below this benchmark. Historically, H.B. Fuller Co's own EV-to-EBIT has ranged from 11.93 to 48.97 over the past decade. While the company's 10-year median is 17.05 vs. the industry median of 17.47, H.B. Fuller Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Chemicals company?
The median EV-to-EBIT among Chemicals companies is 17.47, based on 1,258 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. H.B. Fuller Co's current EV-to-EBIT of 13.90 is 20.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on H.B. Fuller Co and its competitors. For the Chemicals industry, the median EV-to-EBIT is 17.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. H.B. Fuller Co's current EV-to-EBIT is 13.90, which is 18% below median its own 10-year median of 17.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H.B. Fuller Co stock overvalued right now?
H.B. Fuller Co (FRA:HB1) has a current EV-to-EBIT of 13.90. The stock's GF Value™ is €61.38, compared to a current price of €54.50 — trading 11.2% below its estimated fair value. The current EV-to-EBIT is 13.90, which is 18% below median its 10-year median of 17.05 and 20.4% below the Chemicals industry median of 17.47. H.B. Fuller Co's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For H.B. Fuller Co (FRA:HB1), the current EV-to-EBIT is 13.90 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is H.B. Fuller Co (FRA:HB1) Overvalued in 2026?
Based on GuruFocus' analysis, H.B. Fuller Co stock appears to be undervalued.
The current stock price of €54.50 is trading 11.2% below its estimated GF Value™ of €61.38.
Key valuation signals for FRA:HB1:
EV-to-EBIT: 13.90 (18% below median its 10-year median of 17.05)
GF Value™: €61.38 vs. price of €54.50 (11.2% below fair value)
Industry Position: 20.4% below the Chemicals median (#502 of 1258)
No single metric tells the full story. See the FRA:HB1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives, and Construction Adhesives. It generates the maximum revenue from hygiene, health, and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven, and hygiene (disposable diapers, feminine care, and medical garments) and health and beauty. The company generates around half of its revenue in the United States.
81GF Score
Get the complete analysis for FRA:HB1
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:HB1 has been successfully added to your 
